VRTX

NASDAQStock

Vertex Pharmaceuticals Incorporated

$479.41-13.10 (-2.66%)

52-Week Range

$366.54
$513.76

Key Stats

Market Cap

121.8B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.32

Volume

940.1K

Avg Volume

1.4M

Performance

1M

+3.66%

3M

+4.92%

6M

+21.60%

YTD

+5.75%

1Y

-4.93%

3Y

+61.94%

5Y

+117.68%

Price Chart

ETF Exposure

VRTX is held by 370 ETFs

ETFFund NameWeight
SPXLDirexion Daily S&P 500 Bull 3X ETF0.05%
ITDEiShares LifePath Target Date 2045 ETF0.05%
VALTETFMG Sit Ultra Short ETF0.04%
DXUVDimensional - US Vector Equity ETF0.04%
ITDDiShares LifePath Target Date 2040 ETF0.04%
AFTYPacer CSOP FTSE China A50 ETF0.04%
AORiShares Core 60/40 Balanced Allocation ETF0.04%
ITDCiShares LifePath Target Date 2035 ETF0.04%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.03%
AVTMAvantis Total Equity Markets ETF 10.03%
ITDBiShares LifePath Target Date 2030 ETF0.03%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.03%
AOMiShares Core 40/60 Moderate Allocation ETF0.03%
IRTRiShares LifePath Retirement ETF0.02%
AOKiShares Core 30/70 Conservative Allocation ETF0.02%
IALTiShares Systematic Alternatives Active ETF0.02%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF0.01%
THEQT. Rowe Price Hedged Equity ETF0.01%
LVHBInnovator Laddered Allocation Power Buffer ETF0.01%
BDYNiShares Dynamic Equity Active ETF0.00%
PreviousPage 8 of 8

About VRTX ETF Exposure

Vertex Pharmaceuticals Incorporated (VRTX) is held by 370 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 121.8B, VRTX is a widely held institutional stock. The stock currently trades at $479.41. Investors can gain exposure to VRTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VRTX, sorted by portfolio weight.